Electric Dental Handpiece Market are projected to accelerate at a CAGR of 5.2% to close in on US$ 473.1 Mn by 2028

A dental handpiece is an instrument used to hold dental burs, disks, or cups in order to perform tooth removal or to perform cleaning and polishing of teeth or restorative material. The instrument is available in two modalities that includes air driven and electrically driven handpieces. It is powered by either electric motor or air turbines.

A new research report by Future Market Insights titled ‘Electric Dental Handpiece Market: Global Industry Analysis 2013–2021 and Opportunity Assessment 2022–2028’ gives clear insights on the market and its various segments. According to the analysis, the global electric dental handpiece market recorded a market value of over US$ 270 Mn in 2012, and is expected to reach a valuation in excess of US$ 450 Mn by the end of 2028. The market is anticipated to grow at a CAGR OF 5.2% during the forecast period. The market growth will make many companies focus solely on providing dental handpieces. Manufacturers are developing electric brushless motors to be used in various dental settings for a large number of applications. Tie-ups with distributors and other channel partners ensure continuous product availability and will help in expanding product reach both geographically and in non-traditional end use settings.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2012

Electric Dental Handpiece Market: Dynamics

The growth of the global electric dental handpiece market is helped by a lot of factors. Mostly the technological advancements have been a contributor in the market’s growth. The increase in dental disorders also plays a crucial role in augmenting market revenue. People have started using more artificial products and there is a visible increase in the carelessness towards teeth, which has increased the rate of dental disorders. There is also an increase in the spending of people on costly dental treatments.

However not every region is economically stable, which makes certain countries within such regions incapable of purchasing these costly instruments. Stringent regulations on the manufacturing of dental devices in under developed regions can be a factor that restricts revenue growth of the global electric dental handpiece market.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-2012

Segmental Analysis

  • Based on the regional analysis, North America dominates the market with a higher revenue share than other regions. However, Western Europe is expected to lead in terms of a high CAGR of 5.7% during the forecast period
  • Based on motor type, brushless motors is the dominating segment of the market, and it is also the fastest growing segment with a CAGR of 5.8% during the forecast period
  • In terms of end user, the dental clinics segment leads the market with the maximum revenue and the highest growth rate

Global Electric Dental Handpiece Market: Competitive Landscape

This research report lists the top companies in the market along with brief business profiles. These profiles include the current as well as the future strategies of the companies studied. According to the market analysis, A-dec Inc. held the maximum revenue share in 2016. Some of the other major players mentioned in the report include KaVo Dental GmbH (Danaher Corporation), Dentsply Sirona Inc., Nakanishi Inc., A-dec Inc., Bien-Air Medical Technologies, SciCan Ltd., DentalEZ Group, Brasseler USA, W&H Dentalwerk Bürmoos GmbH, Lares Research etc.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-2012

Key Segments of Electric Dental Handpiece Industry Survey

Electric Dental Handpiece Market by Motor Type

  • Brush Motors
  • Brushless Motors

Electric Dental Handpiece Market by End User

  • Hospitals
  • Dental Clinics
  • Others

To know more about the global electric dental handpiece market, contact our analysts at press@futuremarketinsights.com

Wearable Blood Pressure Monitor Market In-Depth Analysis, Growth Strategies and Comprehensive Forecast to 2029

This Wearable Blood Pressure Monitor market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Wearable Blood Pressure Monitor market.

Wearable blood pressure monitors are smaller than the traditional blood pressure devices. Most wearable blood pressure monitors are digital and the new smart wearable blood pressure monitors are operated through apps. Wearable blood pressure monitors are available in three basic forms, which are wrist blood pressure monitor, upper arm blood pressure monitor, finger blood pressure monitor. Among all types of wearable blood pressure monitors, the wrist wearable blood pressure monitors are of particular interest due to the easy use and non-bulky look and design. With the advancement in technology the wrist based wearable blood pressure monitors are becoming sleeker and slim such as the recently launched Omron’s Heart Guide. The device looks like a smart watch, and also has the features of a smart watch. The Heart Guide is a step towards in the inclusion of blood pressure monitoring through a fitness tracker. Further advancement in technology for wearable blood pressure monitors is expected to drive the growth and adoption of wearable blood pressure monitor market globally, throughout the forecast period.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9401

Wearable blood pressure monitor Market: Drivers and Restraints

Increasing prevalence of hypertension, increase in healthcare spending and rise in adoption of wireless and wearable technology are some of the factors that drive the growth of wearable blood pressure monitors. Others factors such as increase in ageing population and rise in cardiovascular disorders also drive the growth of wearable blood pressure monitors. However, increased cost of wearable blood pressure monitors, lack of precision when compared to conventional devices and compatibility issues with other devices are some of the factors that may hinder the growth of the wearable blood pressure monitor market.

Wearable blood pressure monitor Market: Overview

Increase in hypertension population is primarily driven by changes in lifestyle and adoption of sedentary lifestyle. The increase in fast pace lifestyle has moved patients from regular visit to doctor to opting the use of compatible, easy to use wearable blood pressure monitors. Wearable blood pressure monitors are currently still being developed from wireless upper arm monitors to bulky wrist monitors to recently FDA approved watch type of blood pressure monitors. With the advancement in technology the adoption of such wearable blood pressure monitors is expected to rise during the forecast period there by driving a significant growth of the wearable blood pressure monitor market.

Request Brochure of Report: https://www.futuremarketinsights.com/reports/brochure/rep-gb-9401

Wearable blood pressure monitor Market: Regional Outlook

North America and Europe take the maximum share of the Wearable blood pressure monitor market. Increased adoption of advance technology, rise in healthcare spending, and increase in awareness in these regions are some of the factors that drive the growth of the Wearable blood pressure monitor market. However Asia Pacific region is expected to have the a significantly high growth rate due to increasing aging population, rise in hypertension patient pool in the region and need for continuous or periodic monitoring of patients.

Wearable blood pressure monitor Market: Key Players

Some of the Key players in the Wearable blood pressure monitor market include, Blipcare, iHealth Labs Inc., OMRON Corporation, Koninklijke Philips N.V., Pyle Audio, ForaCare Suisse AG, Qardio, Inc., Xiaomi, Medaval Ltd., Nokia Corporation, Koogeek Inc., and Inventum Huishoudelijke Apparaten B.V., among many others.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-9401

Wearable blood pressure monitor Market: Segmentation

The global Wearable blood pressure monitor market is segmented by product type, indication, end users and region:

Based on the product type, the global Wearable blood pressure monitor market is segmented into:

  • Wrist Blood Pressure Monitor
  • Upper arm Blood Pressure Monitor
  • Finger Blood Pressure Monitor

Based on the connecting technology, the global Wearable blood pressure monitor market is segmented into:

  • WiFi Based
  • Bluetooth Based

Based on the end users, the global Wearable blood pressure monitor market is segmented into:

  • Healthcare facilities
  • Home Care Settings

Infection Prevention Market is projected to rise at a CAGR of 4.2% during 2021 – 2031

According to a recent study by Future Market Insights (FMI), sales of infection prevention products are expected to top US$ 37.4 Bn in 2021, at a CAGR of over 4.2% during the forecast period (2021-2031).

Rising cases of infectious diseases caused due to the pathogenic organisms such as bacteria, fungi, viruses and other parasitic organism are improving the adoption of infection preventing products.

As reported by the Centre for Disease Control and Prevention (CDC) in 2018, infectious disease is the third most leading cause of death in the U.S. followed by other infectious diseases such as tuberculosis (9,025 cases), salmonella (60,99 cases), Lyme disease (33,666 cases), meningococcal disease (327 cases) and parasitic diseases (15.5 Mn cases).

Several other factors such as rising incidence of infections acquired while in hospital (often called as Hospital Acquired Infections or HAI), large number of surgical procedures, and increasing cases of chronic diseases among geriatric population have led to higher emphasis on maintaining proper hygiene and cleanliness.

Sudden outbreak of pandemic increased the number of patients in hospital during the FQ-20, elevating the risk of viral transmission amongst them. This in turn has created the demand for infection preventing and controlling options such as the use of hand sanitizers, disinfectants and other such products.

Increase in sales of these infection prevention products is expected to boost the infection prevention market growth in near future. The market registered spike in demand for infection preventive products, especially in emerging economies such as India.

As per Future Market Insights, the India infection prevention market registered highest growth across South Asia, reaching US$ 17.29 Bn in 2021.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13950

Additionally, companies manufacturing infection prevention products have been focusing on developing eco- friendly and sustainable bio-based products with superior efficacy. Drive towards sustainability is expected to strengthen infection prevention market, creating worthwhile opportunities for growth.

Increasing ageing population worldwide has resulted in higher focus on proper hygiene and self-care solutions due to the rise in chronic diseases and onset of COVID-19. Furthermore, increase in consumer spending, improved healthcare infrastructure, rising government and industry investments in research and development activities will create demand for infection prevention product.

Based on the aforementioned factors, Future Market Insights (FMI) estimates that the market is expected to create absolute $ opportunity, exceeding more than US$ 56.39 Bn by 2031-end.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-13950

Key Takeaways from Infection Prevention Market Study

  • By product, sterilization equipment is the most lucrative segment in terms of revenue and is anticipated to grow at a CAGR of more than 4.9% during 2021-2031.
  • Based on end-user, hospitals and clinics segment is leading the market and expected to gain more than 42% of revenue share through 2031.
  • The U.S. is expected to dominate the global infection prevention market in terms of revenue in 2021, followed by the U.K. and Germany.
  • India is expected to be the most lucrative market in terms of revenue across South Asia, accounting for over 50% of market value share in 2021.
  • China holds leading position in East Asia and is expected to account for nearly 48% of market share.

“Backed by the unprecedented outbreak of COVID-19, demand for infection preventing products is increasing. Key players are introducing products made from sustainable and eco-friendly materials to gain competitive edge,” says the FMI Analyst.

Who is Winning?

Some of the leading manufacturers of infection prevention products are focusing on new product development, clinical trials, speedy regulatory approvals, exclusive marketing and distribution licensing agreement strategies, thereby enhancing their market presence.

  • In 2021, a new 3M™ Clean & Protect Certified Badge Program was launched by 3M company. A new comprehensive system designed for effective cleaning and disinfecting solution that cleans, monitors and protects the facilities.
  • In July 2020, Reckitt Benckiser Group PLC in partnership with water.org made provisions for improved access to safe, clean water in Kenya. In the same month, the company received the EPA approval for the first surface disinfectant products tested on the SARS-COV-2 virus.
  • In 2021, Metrex collaborated with Solvay for chemical resistance testing of widely-used disinfectants in healthcare settings.

The key market players covered by FMI include Cantel Medical, Getinge AB, STERIS, ASP (Advanced sterilization Products), Sotera Health, 3M, Ecolab, Halyard Worldwide, Inc. (Halyard health), Matachana Group, Belimed, Inc., Pal International, Reckitt Benckiser Group PLC., Metrex Research, LLC., Terumo Corporation, Ahlstrom Munksjo and Ansell Ltd.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-13950

Infection Prevention Market by Category

By Product:

  • Sterilization Equipment
  • Disinfectors
  • Consumables
  • Protective Apparel & Textiles
  • Infectious Waste Disposal

By End User:

  • Hospitals & Clinics
  • Pharmaceutical Companies
  • Clinical Laboratories
  • Medical Device Companies
  • Life Sciences Industries
  • Academic and Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

Acute Kidney Injury Treatment Market is projected to exhibit a noteworthy 8% CAGR over the forecast period 2019–2029

Growing prevalence of acute kidney injury as well as increasing early diagnosis with subsequent increasing treatment seeking rate are the prime drivers of the global acute kidney injury treatment market. Treatment such as dialysis therapies has resulted in better management of acute kidney injury, and has helped reduce the risk of various kidney-related diseases. Various organisations are involved in acute kidney injury disease surveillance. In 2017, China’s central government issued the 13th Five Year National Science and Technology Innovation Plan, which aims to create a national platform to share biomedical big data, develop technologies for precision medicine, and integrate them into a multilevel knowledge database, leading the healthcare treatment market to new growth avenues.

The global acute kidney injury treatment market is projected to exhibit a noteworthy 8% CAGR over the forecast period (2019–2029).

“Increasing prevalence of acute kidney injury across the world and increasing number of dialysis centers are prominent factors augmenting the growth prospects of the global acute kidney injury treatment market.”

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9399

Key Takeaways of Acute Kidney Injury Treatment Market Study

  • Owing to increasing acute kidney injury prevalence, number of dialysis centers, and efficient treatment method, the dialysis segment is expected to be a significant revenue generator.
  • The intermittent hemodialysis segment, under product, in the acute kidney injury treatment market, is expected to be a prominent segment, as results provided by this treatment are more efficient as compared to other dialysis methods.
  • The pre-renal injury segment is anticipated to dominate the acute kidney injury treatment market, as pre-renal injury is more prevalent in patients with acute kidney injury.
  • North America is expected to dominate the global acute kidney injury treatment market in terms of revenue, owing to the growing adoption of advanced treatments over conventional methods. East Asia is expected to offer lucrative opportunities for the acute kidney injury treatment market during the forecast period.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9399

Advanced Technology & Product Launches – Key Strategies Followed by Manufacturers

Advancements in diagnostic technology and more product availability in order to streamline their product offerings in respective regions with diverse product portfolios are being followed by players in the acute kidney injury treatment market. For instance, in January, 2019, Fresenius Medical Care launched the 4008A dialysis machine to improve accessibility to life-sustaining dialysis treatment.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-9399

More Valuable Insights on Acute Kidney Injury Treatment Market

Future Market Insights brings a comprehensive research report on forecast revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each segment from 2014 to 2029. The global acute kidney injury treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the readers. The study provide compelling insights on the acute kidney injury treatment market on the basis of product (dialysis and drug therapy), injury (pre-renal injury, intrinsic renal injury, and post-renal injury), and distribution channel (hospitals, ambulatory surgical centers, and others), across seven major regions.

For additional information, write to the analyst at press@futuremarketinsights.com

Femtech Market is expected to reach US$ 3.8 Bn by 2031, growing at a CAGR of 15.0% from 2021- 2031

Femtech is a term used for female technology which involves the use of digital health tools including software, diagnostics, products, and services that are targeted at women’s health. According to a recent Future Market Insights (FMI) report, the global femtech market is estimated to hit a valuation of US$ 948.1 Mn in 2021, with a market CAGR of 15.0% during the forecast period (2021-2031).

Market demand is set to rise at a steady pace throughout the forecast period, majorly favoured by investments outside the boundaries of healthcare towards a branched approach involving domains such as workplace regulations, financial equity, and state legislation.

The primary factor supporting the femtech market to positive expansion in terms of growth and stability is the advent of digitalization and artificial intelligence. Technological advancements such as cloud-based informatics allow personalized solutions, driven by consumer input. This has given rise to affordable and accessible analysis in terms of personal health monitoring and diagnosis.

Key market players have pushed for innovation and accessibility into customized digital solutions. This also includes the introduction of hands-free wearables which are assistive with the regular, day-to-day life of women across the globe.

Additionally, leading product developers in the femtech market work through commercial partners such as department stores, big-box retailers, hospitals, clinics, insurance companies, pharmacies and drugstores, private medical practices and e-commerce platforms to expand product sales prospects.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-11761

Key Takeaways from Femtech Market Study

  • Menstrual health applications will drive market growth holding around a third of the market, supported by growing purchases from the working women demographic.
  • Diagnostic services are projected to cover about 45% of the global market by 2031. This is aided by the growing accessibility of digital health services
  • The U.S. holds a dominant share, valuing at over US$ 357.1 Mn by the end of 2021, supported by the presence of leading players and higher consumer acceptance.
  • The U.K. and Germany dominate the Europe market, cumulatively accounting for more than 25% of the regional revenue.
  • China is a leading market in East Asia, and is forecast to account for more than 50% of the regional value share owing to a vast consumer base.

“The advent of technological improvements in healthcare in the form of devices, applications, services, and products has increased the rate of diagnosis of reproductive disorders in terms of time management and treatments for women. This will aid growth through the upcoming decade,” says the FMI Analyst

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-11761

Who is Winning?

Some of the leading companies operating in the femtech market are focusing on collaborations with leading institutions for increasing awareness among the population about the adoption of digital health services.

Collaborations with key pharmaceutical companies to launch customized products and services for the growing consumer base has led key players to retain their position in the market while expanding their product portfolio.

  • Research collaboration in monitoring fetal heart rates through wearable ECG chips by between Bloomlife and Imec in 2019 has expectantly given rise to superior monitoring capabilities in maternity care.
  • Femtech companies have integrated applications for tracking fertility and offer services such as in-vitro fertilization. Additionally, they also offer medical treatments and products such as wearables and hands-free devices.

Key market players covered by FMI include Clue, Aparito Limited, Bloomlife, Bonzun Health Information AB, Elvie, Ava Science Inc., Grace Health, iBreve, LactApp, Natural Cycles Nordic AB, Hera Med Ltd., Niramai Health, NURX Inc., SteadySense GmbH, Pregnolia AG, Willow, WOOM and B-wom.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-11761

Want More Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global femtech market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the femtech market based on service (diagnostics, monitoring, therapeutic), application (general health and wellness, maternity care, menstrual health, pelvic and uterine healthcare, cancer and chronic disease), and end-user (direct-to-consumer, hospitals, surgical centres, fertility clinics, diagnostics centres) across seven major regions.

Global Pneumococcal Vaccines Market Is Expected To Surpass A Valuation Of US$ 10124.9 Million By 2021, Expanding At A Value-Based CAGR Of 7.37% During The Forecast Period 2021 To 2031

Increasing incidence of pneumococcal diseases such as pneumonia, meningitis, and bacteremia is driving the market growth. According to a report published by Centers of Disease Control and Prevention in 2018, over 150,000 people in the U.S. are required emergency medical assistance due to pneumonia and approximately 3,500 deaths are reported in the country because of bacteremia and meningitis.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-7078

Kids under the age of 5 years and adult over 65 years of age a more vulnerable to pneumococcal diseases. Pneumococcal vaccines plays a significant role in safeguarding people and also assist in the treatment of these diseases. Thus, the demand to curb the rising incidence of pneumonia is expected to create lucrative growth opportunities for the market.

Government and various organization such as UNICEF, the WHO, and others across the globe are taking initiatives to spread the awareness and reduce the burden of pneumococcal diseases. Attributed to this, the public health agencies is expected to remain the dominant the distribution channel segment over the next ten years.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-7078

Key Takeaways from FMI’s Pneumococcal Vaccines Market Study

  • The U.S. is anticipated to dominate the North America market on the back of high prevalence of pneumococcal diseases
  • The market in the U.K. is likely to grow at a steady pace, owing to the presence of leading market player in the country.
  • India will emerge as a highly lucrative market favored by the increasing number of government initiatives to curb the prevalence of pneumococcal diseases
  • Due to large pool of coronavirus and number of medical institutes and hospitals in China, the market in the country is likely to project rapid growth.
  • Based on product type, pneumococcal conjugate vaccines is estimated to lead the segment, supported by the increasing number of children vaccination programs.

“Several healthcare institutes, research centers, and leading manufacturers are focusing on research and development (R&D) and clinical trials for developing novel pneumococcal drugs to address the demand for vaccines for multiple serotypes. Their efforts are estimated to bode well for the market, spurring the sales,” says the FMI analyst.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-7078

Competitive Landscape

Leading players operating in the pneumococcal vaccines landscape are increasingly investing in research and development and conducting clinical trial for developing novel pneumococcal drugs. Besides this, some of the market players are focusing on receiving approvals from regulatory bodies to launch the products. For instance,

In January 2021, Pfizer Inc,, one of the leading pharmaceutical company, announced receiving an approval from the U.S. Food and Drug Administration (FDA) for its new drug named, PREVNAR 20. It is a pneumococcal conjugate vaccines for prevention of invasive disease and pneumonia caused by 20 pnemococcus stereotypes in adults aged 18 years or older.

On-site Preventive Care Market to reach USD 33.8 billion by 2028

Future Market Insights has published a new report titled “On-site Preventive Care Market: Global Industry Analysis (2017-2021) and Opportunity Assessment (2022-2028).” The report states that the standards set in the workplace for the safety of workers and the need to adhere to workplace norms have triggered the demand for on-site preventive care. Moreover, the increasing incidences of workplace illness has also made it an obligation for employers to follow employee safety codes and adopt on-site preventive care. As a result, the global On-Site Preventive Care Market is expected to witness a CAGR of 7.1% from 2022 to 2028. The market was worth around US$ 16,135 Mn in 2022 and is likely to touch a valuation of US$ 32,063 Mn approximately by the end of 2028.

On-site clinics enable employees to receive the required essential care at the time of emergency without having to leave the workplace. The clinicians in these clinics also aid employees in searching for a primary care physician who they can consult with on a regular basis. As a Future Market Insights analyst quotes, “Changes in lifestyle among the working class have incessantly impelled employers to establish certain behavioural standards within the workplace. This is one of the core factors responsible for the growing adoption of on-site preventive care in several organisations across the globe.”

To remain ‘ahead’ of your competitors, request for a sample-  https://www.futuremarketinsights.com/reports/sample/rep-gb-5518

Burgeoning Penetration of Workplace Wellness Programmes to Bode Well for the Market

In the recent past, workplace wellness programmes have earned the merit of being one of the most adopted healthcare services in the world. It has been further expected that its adoption will increase in the coming years owing to the implementation of the Affordable Care Act. This act is expected to promote an increase in the employee-based coverage of workplace wellness and also promote these programmes through several provisions. Moreover, the growing incidences of chronic diseases among the working population have also become a matter of concern and this has compelled employers across the globe to adopt as well as promote workplace wellness programmes.

Furthermore, employers who have adopted on-site preventive care services have reported enhanced performance ranging from heightened morale and cost savings to productivity. The death of time, access, and cost along with misunderstanding of the benefits of prescribed wellness programmes result in the underutilisation of primary care services. As a result, employees flood emergency rooms, missing out on critical preventive care measures and also leave chronic conditions go unmanaged. In this regard, on-site clinics provide employees with the necessary support without having to leave their work and plus the clinicians also work together with the patients in a cohesive environment to address their various health related issues.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-5518

North America and Western Europe to Compete Neck and Neck

In 2017, North America held a share of 37.0% in the global on-site preventive care market closely trailed by Western Europe. The dominance of North America can be attributed to the several policies implemented by the U.S. government pertaining to employee safety and the adoption of certain employee codes of safety. The U.S. is also an extremely mature market owing to the high adoption of workplace wellness programmes.

Companies to Innovate Services in the Global Market

In order to stay ahead of the competition, several companies operating in the global market are focussing on innovating their existing services and integrating new services. Some of the leading companies in the market are Premise Health, OnSite Care, Inc., PrevMED, RepuCare, Healthcare Solutions Centers, LLC, McCormack & Kale Motiva Health & Chiropractic, Inc., Marino Wellness, Kinema Fitness, and TotalWellness.

Reasons to Buy the report

  • We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
  • Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
  • The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

For in-depth competitive analysis, Buy Now-  https://www.futuremarketinsights.com/checkout/5518

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

3D Printed Medical Devices Market to experience a significant growth rate of 16.1% CAGR from 2022 to 2028

Until late 2016, the key focus of most leading players in the 3D printed medical devices market was geographic expansion through acquisition and merger. In May 2016, Johnson & Johnson announced collaboration with a subsidiary of HP Inc. for manufacturing personalized healthcare solutions at reduced costs through 3D printing techniques. J&J collaborated with Organovo to carry out feasibility study on bio printed human tissue for testing new medications to work with Carbon 3D, famous for ultra-fast Continuous Liquid Interface Production (CLIP) technology for production of custom surgical devices.
The focuse is now gradually shifting towards expansion through strategic partnerships to improve their distribution network. For instance, in 2017, Envision partnered with ScanSource, Inc. to deliver 3D printing solutions to resellers in the Americas. Similarly, in 2018, 3D Systems and Stryker announced distribution partnership for VSP (Virtual Surgical Planning) and anatomical models for carniomaxillofacial specialty.

Currently heading towards a market value of over US$ 440 Mn, the global market for 3D printed medical devices is projected for stupendous growth at 16% CAGR during 2019 – 2029. North America will remain the leading market for 3D printed medical device sales, whereas the market attractiveness of Asia Pacific has been rising notably.

To remain ‘ahead’ of your competitors, request for a sample
The market growth is primarily assisted by advancements in 3D printing technology, surging government spending in healthcare sector, increasing usage of 3D printed medical devices for medical procedures, and relative simplification of the manufacturing process of 3D printed medical devices. Introduction of Computer-aided Design (CAD) for 3D printing can create trail ready devices, thereby reducing manufacturing time, time to market as well as operational cost.

Key Takeaways – 3D Printed Medical Devices Market Study

• Although metals and alloys are most preferably used for 3D printed medical devices, biomaterial inks are expected to gain traction during the forecast period owing to their highly biocompatible and versatile physical properties.
• PolyJet – InkJet 3D printing technology currently holds maximum share of 3D printed medical devices market. However, consistent development and adoption of innovative technologies may reduce the 3D printed medical devices market share of this technology during the forecast period.
• Use of 3D printing technology in orthopedic implants is shaping the future of 3D printed medical devices market. It currently accounts for nearly half of the market value.
• The consistently expanding patient pool and growing preference for personalized implants in joint replacement surgeries will remain key boosters to growth of 3D printed medical devices demand in orthopedics.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1501

3D PRINTED MEDICAL DEVICES MARKET STRUCTURE ANALYSIS

• Key players are focusing on strengthening their position by establishing new facilities in North America. In order to increase their revenue share, major players in North America are entering into agreements with hospitals and academic institutes.

• Various manufacturers are targeting Asia and Europe through distribution agreements with local players.

• Some of the key players in the 3D printed medical devices market include

1. 3D Systems, Inc.,
2. EnvisionTEC, and
3. EOS GmbH Electro Optical Systems among others.

• Large medical device manufacturers are increasingly gaining interest in 3D technology for manufacturing. These medical device companies are thus investing in 3D technology through acquisitions. For an instance, GE Healthcare acquired 95% of share of Arcam AB in December 2017.

Learn More About Report Inclusions
Future market insights offers a unique perspective and actionable insights on 3D printed medical devices market in its latest study, presenting historical demand assessment from 2014 – 2018 and projections from 2019 – 2029 based on application (orthopedic implants, dental implants, carnio-maxillofacial Implant), material type (metals and alloys, biomaterial inks and plastics) technology (stereolithography (SLA) – liquid-based 3D printing, selective layer sintering (SLS) – powder-based 3d printing, digital light processing(DLP), fused deposition modelling (FDM)-plastic filament extrusion-based, polyjet – inkjet 3D printing, electronic beam melting (EBM) ) end user (hospitals, ambulatory surgical centers, diagnostic centers) in seven key regions.

For in-depth insights, Download a PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1501

3D PRINTED MEDICAL DEVICES MARKET TAXONOMY

FMI’s study on the 3D printed medical devices market offers information divided into five important segments – application, material type, technology, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Application

  • Orthopedic Implants
  • Dental Implants
  • Carnio-Maxillofacial Implant

Material Type

  • Metals and Alloys
  • Biomaterial Inks
  • Plastics

Technology

  • Stereolithography (SLA) – Liquid-based 3D Printing
  • Selective Layer Sintering (SLS) – Powder-based 3D Printing
  • Digital Light Processing(DLP)
  • Fused Deposition Modelling (FDM)-Plastic Filament Extrusion-based
  • PolyJet – InkJet 3D Printing
  • Electronic Beam Melting (EBM)

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • JAPAN
    • Middle East and Africa

 

Surface Plasmon Resonance Market 2022 by Global Key Players, Types, Applications, Countries, Industry Size and Forecast to 2029

Increasing adoption of label-free detection techniques over labelled detection techniques is due to their cost-effective nature. Additionally, the availability of versatile products coupled with surface plasmon resonance to enhance the specificity of tests is an important factor that will bolster the demand for surface plasmon resonance. Imaging systems help in increasing throughput at a remarkable speed and with precise motion and consistency in report generation. Furthermore, the introduction of multifunctional products for improved outcomes is also expected to drive the growth of the surface plasmon resonance market over the forecast period.

The global surface plasmon resonance market is projected to reach a market value of US$ 770 Mn in 2019, increasing at a decent CAGR of 6% over the forecast period of 2019 – 2029.

“Increasing application of surface plasmon resonance in the field of drug discovery and medical imaging is contributing to the growth of the surface plasmon resonance market. Development of new technologies coupled with surface plasmon resonance, such as nanoparticle surface plasmon resonance and microfluidics, is playing an important role in the overall growth of the global surface plasmon resonance market.”

Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-962

Key Takeaways of Surface Plasmon Resonance Market Study

  • The market share of imaging systems is evaluated to grow at a significant rate by the end of 2029, as these are the ideal solution for the analysis of label-free and multiplexed biomolecules.
  • Sales of surface plasmon resonance are envisaged to be higher in North America. Increasing adoption of imaging systems and biosensors in life science R&D is anticipated to boost the growth of the surface plasmon resonance market in the region.
  • Innovation while developing imaging software used in surface plasmon resonance for the analysis of kinetic parameters of biomolecular interactions is a key aspect for increasing the reproducibility of results. Companies are investing in R&D initiatives to introduce superior imaging devices with enhanced magnification, to observe the smallest deflection in the refractive index, thus aiding the growth of the surface plasmon resonance market.

Any Queries, ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-962

Adoption of Label-free Detection Technique for Analysis of Biomolecules

Detection of biological analytes through their physical properties is difficult. As a result, researchers rely on the addition of some sort of label to one or more of the analytes that need to be studied. Inclusion of this label for increasing specificity and accuracy has increased the cost of reagents and assays. To reduce assay cost and complexity while providing more qualitative information through labelled detection, adoption of the label-free detection technique such as surface plasmon resonance has increased, and is expected to fuel the growth of the global surface plasmon resonance market during the forecast period. The label-free detection technique simplifies the procedure by reducing the time and effort required for the development of the assay. Thus, increasing adoption of label-free detection techniques over labelled detection is expected to boost the growth of the global surface plasmon resonance market.

Want more insights?

The surface plasmon resonance market report, a new study by Future Market Insights, opines on the evolution of the global surface plasmon resonance market from 2014–2018, and presents demand projections for 2019–2029, on the basis of product type (imaging systems, sensor systems, and reagents), application (drug delivery, material science, and biosensors), and end user (academic and research institutes, food and beverage industry, biopharmaceutical companies, CROs, and others), across seven prominent regions.

Buy Industry Research Report @ https://www.futuremarketinsights.com/checkout/962

Reasons to Buy the report

  • We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
  • Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
  • The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Global Peripheral Vascular Stents Market Reached A Valuation Of Around US$ 3.5 Bn In 2021, And Is Expected To Attain A Net Worth Of US$ 5.3 Bn By 2028

According to the latest market report published by Future Market Insights, titled ‘Peripheral Vascular Stents Market: Global Industry Analysis 2013 – 2021 and Opportunity Assessment 2022 – 2028’, the global peripheral vascular stents market is expected to expand at a CAGR of 6.6% over the forecast period 2022–2028.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-2091

FMI estimates that the global market for peripheral vascular stents is to be valued at US$ 2,822.5 Mn in 2022 and is expected to expand at CAGR of 6.6% over 2022–2028, to reach US$ 5,324.1 Mn by 2028 end. Based on product type, the self-expanding stents segment dominated the global peripheral vascular stents market, with over 52.1% value share in 2021. The segment is expected to grow at above 6.6% CAGR over the forecast period.

North America is expected to maintain its dominance in the global market due to regulatory approval of several new products such as drug eluting stents in the U.S., Europe and Japan. Increasing awareness of peripheral surgeries and prevalence of peripheral artery disease in developing countries such as India and Brazil remains the major factor driving the demand for peripheral vascular stents. Increasing in number end users and growing number of ambulatory surgical centres are the other major factors expected to drive the growth of the global peripheral vascular stents market.

An intravascular stent is a synthetic tubular mesh structure used for permanent implant in graft or native vasculature. A stent is basically designed to provide mechanical radial support after assigning; the support is meant to improve vessel patency over the life of the device. After the stent is placed in the intended location, it is expanded by a balloon or self-expanding mechanism.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-2091

Global Peripheral Vascular Stents Market: Segmental Forecast

The global peripheral vascular stents market has been segmented on the basis of product type, artery type, end user and regions. Globally, the self-expanding stents is expected to be the most attractive segment from the manufacturers’ point of view. Although there is a high demand for drug eluting stents and the segment leads in terms of market volume in the forecast period, high price of drug eluting stents would lead to low revenue contribution of the product type segment. Among all the artery types, high demand of peripheral stents is expected to come from iliac artery segment due to growing prevalence for peripheral artery disease in many countries across the globe.

Global Peripheral Vascular Stents Market: Regional Analysis

In terms of value, the global peripheral vascular stents market is expected to expand at 6.6% CAGR over the forecast period of 2022–2028. With nearly 48.5% market share, North America dominated in the global peripheral vascular stents market in 2021, partly due to penetration of newly approved drug eluting stents in the U.S. Western Europe is expected to be the second large market globally, with the U.K., Italy, France and Germany being countries with high growth rates. APEJ is expected to be the second large market for peripheral vascular stents, primarily due to improving immunization access and availability of cost-effective surgeries.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-2091

Global Peripheral Vascular Stents Market: Competition Tracking

The market for peripheral vascular stents is consolidated with few players contributing over 55% of revenue share. The key players identified in the global market include Medtronic Plc., Becton, Dickinson and Company, Cardinal Health, Inc., B. Braun Melsungen AG, MicroPort Scientific Corporation, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Abbott Laboratories, W.L. Gore & Associates Inc., and Cook Medical Inc., among others. Acquisition of established products to gain immediate growth is the key strategy adopted by key players in the market.